Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$481K Sell
4,071
-73
-2% -$9.03K 0.2% 106
2025
Q4
$521K Sell
4,144
-521
-11% -$68K 0.2% 104
2025
Q3
$683K Sell
4,665
-79
-2% -$11.9K 0.27% 89
2025
Q2
$740K Sell
4,744
-30
-0.6% -$4.76K 0.33% 75
2025
Q1
$786K Sell
4,774
-30
-0.6% -$4.99K 0.34% 73
2024
Q4
$783K Buy
4,804
+30
+0.6% +$5.37K 0.45% 69
2024
Q3
$933K Sell
4,774
-35
-0.7% -$6.45K 0.53% 60
2024
Q2
$834K Buy
4,809
+2,167
+82% +$361K 0.52% 61
2024
Q1
$447K Buy
2,642
+547
+26% +$102K 0.31% 82
2023
Q4
$413K Sell
2,095
-512
-20% -$90.6K 0.54% 60
2023
Q3
$454K Buy
2,607
+12
+0.5% +$2.18K 0.46% 66
2023
Q2
$447K Buy
2,595
+365
+16% +$63.1K 0.4% 69
2023
Q1
$371K Buy
2,230
+140
+7% +$22.9K 0.36% 74
2022
Q4
$306K Buy
+2,090
New +$309K 0.33% 79

Other funds holding ZTS

Dover Advisors's ZTS Position: Q1 2026 in Review

Dover Advisors reduced its Zoetis (ZTS) stake by 1.8% in Q1 2026, selling an estimated $9.03K and leaving 4,071 shares worth $481K. The position accounts for 0.2% of the portfolio, ranked #106.

Dover Advisors first reported a position in ZTS in Q4 2022 and has held it in 14 quarters since. The position peaked at $933K in Q3 2024. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Dover Advisors held 4,071 shares of Zoetis worth $481K as of Q1 2026.
  • Dover Advisors sold 73 Zoetis shares in Q1 2026, an estimated $9.03K.
  • Zoetis made up 0.2% of Dover Advisors's portfolio in Q1 2026, its #106 holding.
  • Dover Advisors first reported a position in Zoetis in Q4 2022 and has held it in 14 quarters since.
  • Dover Advisors's Zoetis position peaked at $933K in Q3 2024.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Dover Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.